终点和平衡:对结直肠多瘤切除的临床试验进行改革
Zachary L Smith1, Nauzer Forbes2, Srivats Madhavan3
1Division of Gastroenterology and Hepatology, Wisconsin Institute for Research in Endoscopy (WIRE), Medical College of Wisconsin, 8701 Watertown Plank Rd, Hub 6th Floor, Milwaukee, 53226, WI, USA. zsmith@mcw.edu.
Current gastroenterology reports
|September 18, 2025
概括
内镜粘膜切除 (EMR) 试验设计需要更新. 结果和统计数据的创新可以提高结直肠多切除研究的相关性和概括性.
科学领域:
- 胃肠病学 胃肠病学
- 临床试验设计 临床试验设计
- 医学创新 医学创新
背景情况:
- 内镜粘膜切除 (EMR) 已经显著进展.
- 传统的EMR试验设计落后于程序进步.
- 现有的方法限制了相关性和通用性.
研究的目的:
- 审查和评估当前的内镜粘膜切除 (EMR) 试验设计.
- 确定传统EMR试验方法的局限性.
- 为未来的EMR试验提出一个创新的框架.
主要方法:
- 对EMR试验设计方法的文献综述.
- 分析当前方法的局限性.
- 识别来自其他程序学科的方法论创新.
主要成果:
- 在EMR试验设计中,经常使用二进制终点和有限的利益相关者投入.
- 诸如顺序分类和程序主义意识模型等创新可以增强试验.
- 一般化的对比比较和赢得比率提供了先进的分析策略.
结论:
- 改进EMR试验需要在架构上进行转变.
- 整合利益相关者的优先事项,先进的分析和偏见缓解至关重要.
- 现代的框架将为结直肠多切除提供更有意义和更可概括的证据.
更多相关视频
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
32.5K
03:43Structured Approach to Colonoscopy Technique Optimization: A Single-Center Experience with Novice Endoscopists
Published on: July 11, 2025
641
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
